About Brawn Laboratories Limited
Data last updated:
Brawn Laboratories Limited is a public limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 March 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U73200DL1990PLC039653. Its GSTIN is 07AAACB7151N2ZH (Delhi). The company holds 10 GST registrations, of which 8 are active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹99.5 Lakh. It is led by directors including Brij Raj Gupta and Mayank Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C – 64 Lajpat Nagar – 1 Second Floor New Delhi, Delhi, India – 110024.
As per the financials filed for FY 2025, the company reported a revenue of ₹368.56 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹33.01 Cr (net margin 9%) and EBITDA of ₹52.55 Cr (EBITDA margin 14.3%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 15% over five years.
The company has about 552 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Brawn Labs and Brawn Herbals. As per MCA filings, the company has open charges of ₹395.52 Cr and satisfied charges of ₹305.68 Cr on record. Court records list 84 cases involving the company, including 50 filed by the company and 33 filed against it; 21 cases are pending. The company has 3 deals on record (3 secondary share transfers); the latest was in September 2019.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website brawnlabs.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressC – 64 Lajpat Nagar – 1 Second Floor New Delhi, Delhi, India – 110024
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Brawn Laboratories Limited
The main business activity of Brawn Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Brawn Laboratories Limited FY 2024 filings available
Brawn Laboratories Limited reported revenue of ₹368.56 Cr (up 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Brawn Laboratories Limited
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 15% growth in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Brawn Laboratories Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹52.55 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹33.01 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Brawn Laboratories Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Brawn Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Brawn Laboratories Limited
Brawn Laboratories has 4 current directors and 21 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Brij Raj Gupta Also directs: Brawn Biotech Limited, Brawn Cosmetics and Herbals Private Limited | Director | 23 Apr 2003 | 23 Years 5 Months | Current |
| Mayank Jain | Director | 28 Aug 2024 | 2 Years 1 Months | Current |
| Pooja Jha Also directs: Brawn Biotech Limited | Director | 28 Aug 2024 | 2 Years 1 Months | Current |
| Ankit Goyal | Director | 16 Mar 2023 | 3 Years 6 Months | Current |
Ownership and Shareholding of Brawn Laboratories Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Brawn Laboratories Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jul 2025 | Others | ₹7.83 Lakh | Open |
| 09 Jan 2025 | Others | ₹31.34 Lakh | Open |
| 13 Dec 2024 | Others | ₹13.12 Lakh | Open |
| 20 May 2023 | Citi Bank N.A. | ₹50 Cr | Open |
| 03 Mar 2023 | Others | ₹80 Cr | Open |
Total charge records: 38 View all charges
Deals & Funding of Brawn Laboratories Limited
Brawn Laboratories Limited has 3 deals on record (3 secondary share transfers); the latest was in September 2019.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2019 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: A B Pharma Private Limited , 3 individuals |
| Sep 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Brawn Biotech Limited , Balmukund Gupta & Co., 2 individuals |
| Nov 2015 | Secondary share transfer | Undisclosed | Buyer: Brawn Biotech Limited , 3 individuals Seller: 4 individuals |
Full deal history
All 3 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Brawn Laboratories Limited
Brawn Laboratories Limited has 84 court cases on record: 50 filed by Brawn Laboratories, 33 filed against it, 1 where it is another party. 21 cases are pending and 63 are disposed. Status as checked between 21 Sep 2026 and 05 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 49 | 17 | 17 |
| District courts | 33 | 16 | 4 |
| Supreme Court | 2 | 0 | 0 |
Cases on record (5 of 84)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Ajanta Pharma Limited | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed by the company against Ajanta Pharma Limited | Pending |
| Bombay High Court | Court case (COMIP) | Filed by the company against Ajanta Pharma Limited | Pending |
| Bombay High Court | Court case (LPETN) | Filed against the company by Ajanta Pharma Limited | Pending |
| Bombay High Court | Court case (COMIP) | Filed against the company by Ajanta Pharma Limited | Pending |
Full case history
All 84 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Brawn Laboratories Limited
Brawn Laboratories operates two associated brands: Brawn Labs and Brawn Herbals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, research, and global distribution services. | brawnlabs.com | |
| Herbal health and personal care products manufacturing and sales by Brawn Herbals. | brawnherbals.com |
Employees and EPFO Compliance at Brawn Laboratories Limited
Brawn Laboratories Limited has a workforce of 552 employees as of Mar 31, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Brawn Laboratories Limited
Brawn Laboratories has 4 associated companies. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
Recent Activity on Brawn Laboratories Limited
Brawn Laboratories Limited has 25 board changes on record since 2003: 4 appointments and 21 cessations. The latest: Mayank Jain ceased to be Additional Director on 29 Sep 2024.
106 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Brawn Laboratories Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Brawn Laboratories Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Brawn Laboratories Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Brawn Laboratories Limited
Brawn Laboratories has 10 GST registrations: 8 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACB7151N2ZH | Delhi | Active | 13 Dec 2017 |
| 07AAACB7151N3ZG | Delhi | Active | 06 Jun 2022 |
| 06AAACB7151N1ZK | Haryana | Active | 01 Jul 2017 |
| 24AAACB7151N1ZM | Gujarat | Active | 01 Dec 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Brawn Laboratories Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Brawn Laboratories Limited
Brawn Laboratories is an active public limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 March 1990 (36+ years old) and is registered under CIN U73200DL1990PLC039653.
Brawn Laboratories reported revenue of ₹368.56 Cr for FY 2025 (up 15% YoY).
Brawn Laboratories has 4 current directors:
- Brij Raj Gupta - Director
- Mayank Jain - Director
- Pooja Jha - Director
- Ankit Goyal - Director
Brawn Laboratories reported a net profit of ₹33.01 Cr (net margin 9%) and EBITDA of ₹52.55 Cr (EBITDA margin 14.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Brawn Laboratories is 13% over three years and 15% over five years. In the latest year (FY 2025) revenue rose 15%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Brawn Laboratories is 07AAACB7151N2ZH, registered in Delhi. The company has 10 GST registrations in all, of which 8 are active and 2 are cancelled or inactive. Other active GSTINs include 07AAACB7151N3ZG (Delhi), 06AAACB7151N1ZK (Haryana), 24AAACB7151N1ZM (Gujarat).
The CIN (Corporate Identification Number) of Brawn Laboratories is U73200DL1990PLC039653. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Brawn Laboratories has 84 court cases on record: 50 filed by the company and 33 filed against it. 21 are pending. Most are in the high courts.
Brawn Laboratories was incorporated on 27 March 1990, making it 36+ years old. It is registered with the Registrar of Companies, Delhi.
Brawn Laboratories has 3 deals on record (3 secondary share transfers); the latest was in September 2019.